| HIV vaccines: progress to date CM Ling Munier, CR Andersen, AD Kelleher Drugs 71, 387-414, 2011 | 89 | 2011 |
| A systematic review of outcome measures employed in aneurysmal subarachnoid hemorrhage (aSAH) clinical research CR Andersen, E Fitzgerald, A Delaney, S Finfer Neurocritical care 30, 534-541, 2019 | 71 | 2019 |
| Core outcomes for subarachnoid haemorrhage CR Andersen, J Presseau, V Saigle, N Etminan, MDI Vergouwen, ... The Lancet Neurology 18 (12), 1075-1076, 2019 | 39 | 2019 |
| Fire in the belly: A scoping review of the immunopathological mechanisms of acute pancreatitis K Venkatesh, H Glenn, A Delaney, CR Andersen, SC Sasson Frontiers in Immunology 13, 1077414, 2023 | 16 | 2023 |
| Haptoglobin treatment for aneurysmal subarachnoid hemorrhage: review and expert consensus on clinical translation I Galea, S Bandyopadhyay, D Bulters, R Humar, M Hugelshofer, ... Stroke 54 (7), 1930-1942, 2023 | 12 | 2023 |
| The association between hyponatraemia and long-term functional outcome in patients with aneurysmal subarachnoid haemorrhage: a single centre prospective cohort study L Quinn, DH Tian, E Fitzgerald, O Flower, C Andersen, N Hammond, ... Journal of Clinical Neuroscience 78, 353-359, 2020 | 9 | 2020 |
| Mortality and costs related to severe acute pancreatitis in the intensive care units of Australia and New Zealand (ANZ), 2003–2020 SG Barreto, B Kaambwa, K Venkatesh, SC Sasson, C Andersen, ... Pancreatology 23 (4), 341-349, 2023 | 7 | 2023 |
| Patient relevance of the modified rankin scale in subarachnoid hemorrhage research: an international cross-sectional survey N Niznick, V Saigle, ML Marti, J Laframboise, X Zha, C Andersen, ... Neurology 100 (15), e1565-e1573, 2023 | 7 | 2023 |
| Made to measure—selecting outcomes in aneurysmal subarachnoid hemorrhage research CR Andersen, SW English, A Delaney Frontiers in Neurology 13, 1000454, 2022 | 7 | 2022 |
| Liberal or restrictive transfusion strategy in aneurysmal subarachnoid hemorrhage SW English, A Delaney, DA Fergusson, M Chassé, AF Turgeon, F Lauzier, ... New England Journal of Medicine, 2024 | 2 | 2024 |
| Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia P Hastak, D Cromer, J Malycha, CR Andersen, E Raith, MP Davenport, ... Scientific Reports 14 (1), 11102, 2024 | 2 | 2024 |
| Intensive care unit admission criteria: a scoping review J Soares, C Leung, V Campbell, A Van Der Vegt, J Malycha, C Andersen Journal of the Intensive Care Society, 17511437241246901, 2024 | 2 | 2024 |
| Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19 PS Hastak, CR Andersen, AD Kelleher, SC Sasson Frontiers in Immunology 13, 983550, 2022 | 2 | 2022 |
| What to Measure in Aneurysmal Subarachnoid Haemorrhage Research—An International Delphi Survey CR Andersen, J Presseau, B Shea, ML Marti, M McCoy, G Fernie, ... Translational Stroke Research 16 (1), 49-78, 2025 | 1 | 2025 |
| Prioritizing outcome measures after aneurysmal subarachnoid hemorrhage: A q-sort survey of patients, health care providers and researchers CR Andersen, J Presseau, V Saigle, E Fitzgerald, M Lamanna, P Talbot, ... Frontiers in Neurology 13, 1068499, 2022 | 1 | 2022 |
| Delineating the immunological responses in people admitted to the ICU with direct and indirect lung injuries using single-cell RNA sequencing P Hastak, CR Andersen, ZH Zhang, A Lohani, C Phetsouphanh, ... EUROPEAN JOURNAL OF IMMUNOLOGY 54, 1139-1139, 2024 | | 2024 |
| Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia NJ Dharan, SC Sasson, G Ahlenstiel, CR Andersen, M Bloch, G Buckland, ... Plos one 18 (11), e0289907, 2023 | | 2023 |
| Core Outcomes in Critical Care: Development of a Core Outcome Set in Aneurysmal Subarachnoid Haemorrhage Clinical Research CR Andersen | | 2023 |
Anthony DelaneyNorthern Clinical School, Sydney Medical School, University of SydneyVerified email at med.usyd.edu.au